{"status":"success","data":{"title":"PESI Score for Pulmonary Embolism","slug":"PESI","tags":["enoxaparin","warfarin"],"collection":["pulmonary","critical care"],"content":"\n# PESI Score for Pulmonary Embolism\n\n**Pulmonary Embolism Severity Index (PESI) score**\n\n|  Finding                            |  Points         |\n|-------------------------------------|-----------------|\n| Age                                 | +1 per year     |\n| Male gender                         | +10             |\n| Cancer (history of or active)       | +30             |\n| Heart failure                       | +10             |\n| Chronic lung disease                | +10             |\n| Pulse ≥ 110 beats per min           | +20             |\n| SBP &lt; 100 mmHg                   | +30             |\n| RR ≥ 30 breaths per min             | +20             |\n| Temperature &lt; 36C                | +20             |\n| Altered mental status               | +60             |\n| Arterial oxygen saturation &lt; 90% | +20             |                            \n\n\n| Class       | Point Total   |\n|-------------|---------------|\n| Class I     | &lt; 66       |\n| Class II    | 66-85         |\n| Class III   | 86-105        |\n| Class IV    | 106-125       |\n| Class V     | &gt; 125      |\n\n\n## Outpatient Treatment of Pulmonary Embolism (OTPE) trial\n\n*Study design:* Randomized, prospective, non-inferiority clinical trial of 19 ED’s (n = 344 patients) in Switzerland, France, Belgium, and USA looking at morbidity/mortality of PESI class I and II patients\n*Exclusion criteria from study:*\n-   Arterial hypoxemia (O2 saturation &lt; 90% on room air, or paO2 &lt; 60 mmHg)\n-   SBP &lt; 100 mmHg\n-   CP necessitating parental opioids\n-   Active bleeding\n-   High risk of bleeding defined as: CVA during preceding 10 days, GI bleeding in preceding 14 days, or platelets &lt; 75K \n-   Severe renal failure (CrCl &lt; 30 mL per min)\n-   Extreme obesity (body mass &gt; 150 kg)\n-   History of heparin-induced thrombocytopenia or allergy to heparins\n-   Therapeutic oral anticoagulation at time of PE diagnosis (INR ≥ 2)\n-   Any barriers to treatment adherence (current EtOH abuse, illicit drug use, psychosis, dementia, homelessness)\n-   Pregnancy, Imprisonment, Diagnosis of PE &gt; 23 hrs before time of screening\n\n|                                            |  Outpatient  | Inpatient    |\n|--------------------------------------------|--------------|--------------|\n| Recurrent venous thromboembolism ≤ 90 days | 0.6% (1/171) | 0% (0/168)   |\n| Death ≤ 90 days                            | 0.6% (1/171) | 0.6% (1/168) |\n| Major bleeding ≤ 14 days                   | 1.2% (2/171) | 0% (0/168)   |\n| Major bleeding ≤ 90 days                   | 1.8% (1/171) | 0% (0/168)   |\n\n**Outpatient treatment **= **<span class=\"drug\">enoxaparin</span>** 1 mg/kg SQ BID to bridge into PO **<span class=\"drug\">warfarin</span>** (target INR = 2)\n\n**CONCLUSION**: PE patients with PESI class I or II seem safe to manage as outpatients (be aware of exclusion criteria from study)\n\n## References\n\n-   [Aujesky D, Roy PM, Verschuren F, Righini M, Osterwalder J, Egloff M, Renaud B, Verhamme P, Stone RA, Legall C, Sanchez O, Pugh NA, N'gako A, Cornuz J, Hugli O, Beer HJ, Perrier A, Fine MJ, Yealy DM. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet. 2011 Jul 2;378(9785):41-8. doi: 10.1016/S0140-6736(11)60824-6. Epub 2011 Jun 22.](https://www.ncbi.nlm.nih.gov/pubmed/?term=21703676)\n"}}